Axa’s Brightcove, Inc. BCOV Stock Holding History

Axa’s Portfolio BCOV Stock Details BCOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-119,600	Closed	-$933K	–	1241
2022 Q1	$933K	Sell	119,600 -12,500	-9%	-$106K	﹤0.01%	962
2021 Q4	$1.35M	Sell	132,100 -14,100	-10%	-$149K	﹤0.01%	911
2021 Q3	$1.69M	Buy	+146,200	New	+$1.77M	﹤0.01%	890
2018 Q2	–	Sell	-115,200	Closed	-$801K	–	1421
2018 Q1	$801K	Buy	+115,200	New	+$802K	﹤0.01%	1055

Other funds holding BCOV

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

Edenbrook Capital Mt. Kisco, New York $321M AUM 79.21% 1-Year Est. Return

TGM

Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

LLL

Lynrock Lake LP Rye Brook, New York $1.46B AUM 17.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Axa's BCOV Position: Q2 2022 in Review

Axa sold out of Brightcove, Inc. (BCOV) in Q2 2022, closing a stake of 119,600 shares — an estimated $933K sold.

Axa first reported a position in BCOV in Q1 2018 and held it in 4 quarters. The position peaked at $1.69M in Q3 2021. 97 funds tracked by Wall St. Rank hold BCOV as of Q2 2022.

Axa reported no remaining Brightcove, Inc. position as of Q2 2022 after selling out during the quarter.
Axa sold 119,600 Brightcove, Inc. shares in Q2 2022, an estimated $933K.
Axa first reported a position in Brightcove, Inc. in Q1 2018 and held it in 4 quarters.
Axa's Brightcove, Inc. position peaked at $1.69M in Q3 2021.
97 funds tracked by Wall St. Rank held Brightcove, Inc. as of Q2 2022.

Based on Axa's 13F filing for Q2 2022, filed 15 Aug 2022.